Status:
UNKNOWN
Endotherapy for Painless Chronic Pancreatitis
Lead Sponsor:
Changhai Hospital
Conditions:
Pancreatitis, Chronic
Exocrine Pancreatic Insufficiency
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a prospective randomized controlled trial. . Patients will be divided into conservative or endoscopic group and fecal pancreatic elastase-1 (FE-1) is tested to evaluate pancreatic exocrine fun...
Detailed Description
This is a prospective, randomized controlled trial. Patients will be divided into conservative or endoscopic group and FE-1 is tested to evaluate pancreatic exocrine function. The effect of extracorpo...
Eligibility Criteria
Inclusion
- diagnosed with chronic pancreatitis without pain attack related with chronic pancreatitis;
- calcified stone in the cephalic or corporeal portion of the main pancreatic duct with upstream duct dilation;
- no ERCP or ESWL carried out before admission;
Exclusion
- suspected to have malignant tumors;
- history of pancreatic surgery or gastrojejunostomy (Billroth II);
- with end-stage disease;
- pregnancy or lactation;
- refuse to write informed consent
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05261997
Start Date
March 1 2022
End Date
November 1 2023
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433